K-755 Phase 1 study
Phase 1
Completed
- Conditions
- healthy males
- Registration Number
- JPRN-jRCT2080224071
- Lead Sponsor
- Kowa Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- Male
- Target Recruitment
- 78
Inclusion Criteria
healthy males
Exclusion Criteria
subjects who having a history of drug allergy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety<br>adverse events, adverse drug reactions<br>incidence rate
- Secondary Outcome Measures
Name Time Method safety<br>clinical tests<br>change from before administration